EMPIRI receives $500K

cmargain
Feb 9, 2022
1 min read

Excited and grateful that we received $500K from an angel investor, enabling us to move forward with our CLIA LDT certification and prototype testing for CAL, a first-in-class precision cancer diagnostic instrument.

Recent Posts

See All

EMPIRI Co-founder Dr. Kyuson Yun Named as a 2025 Beneficiary in Men of Distinction Program, Benefiting Medical Research and Treatment for Children

6th Annual GCC Innovative Drug Discovery and Development Conference, May 6-7, 2025

Join us for a presentation by Dr. Kyuson Yun titled "E-Slices with Intact TME for Empirical Response Measurements for Immunotherapies and...

Precision Oncology: Emerging Technologies & Implementation

EMPIRI INC.

EMPIRI receives $500K

Recent Posts

Comentarios